Figure 2From: Effects of a dual CCR3 and H1-antagonist on symptoms and eosinophilic inflammation in allergic rhinitis α 2 -Macroglobulin in lavages obtained at baseline and late into the allergen challenge series prior to and after bradykinin challenge in the placebo run (median values with interquartile ranges). Bradykinin produced plasma exudation, a process that may facilitate luminal entry of tissue solutes including tryptase and ECP. (****Denotes p < 0.0001.)Back to article page